English Polski
Vol 19 (2024): Continuous Publishing
Case report
Published online: 2024-07-03

open access

Page views 59
Article views/downloads 31
Get Citation

Connect on Social Media

Connect on Social Media

Ventricular tachycardia and rest ECG suggesting inferior STEMI in a patient with disseminated melanoma with heart involvment.

Katarzyna Alicka-Staszewska1, Maria Magdalena Binkiewicz-Orluk2, Aleksandra Wilk2, Wojciech Król2, Edyta Kostarska-Srokosz1, Wioletta Dyrla1, Marcin Konopka2, Iwonna Grzywanowska-Łaniewska1, Marek Kuch1, Wojciech Braksator2
DOI: 10.5603/fc.99373


The most frequent cardiac tumours are metastases. Despite being a rare cause of symptoms, they occur in the course of disseminated melanoma and concern up to 64% of these patients. The abnormal mass within the heart is often a case of ECG abnormalities suggesting ischaemia — they also might result in the presence of life-threatening arrhythmias. The following study presents a case of a patient with melanoma cardiac metastasis who developed ventricular tachycardia ventricular tachycardia and abnormalities in resting ECG suggesting the evolution of inferior STEMI.

Article available in PDF format

View PDF (Polish) Download PDF file


  1. King DM. Imaging of metastatic melanoma. Cancer Imaging. 2006; 6(1): 204–208.
  2. Glancy DL, Roberts WC. The heart in malignant melanoma. A study of 70 autopsy cases. Am J Cardiol. 1968; 21(4): 555–571.
  3. Cates CU, Virmani R, Vaughn WK, et al. Electrocardiographic markers of cardiac metastasis. Am Heart J. 1986; 112(6): 1297–1303.
  4. Tas F. Metastatic behavior in melanoma: timing, pattern, survival, and influencing factors. J Oncol. 2012; 2012.
  5. Judge JM, Tillou JD, Slingluff CL, et al. Surgical management of the patient with metastatic melanoma to the heart. J Card Surg. 2013; 28(2): 124–128.
  6. PDQ®Adult Treatment Editorial Board PDQ Melanoma Treatment. https://www.cancer.gov /types/skin/patient/melano ma-treatment-pdq (04.04.2024).
  7. Lyon AR, López-Fernández T, Couch LS, et al. ESC Scientific Document Group. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022; 43(41): 4229–4361.
  8. Binkiewicz-Orluk M, Konopka M, Kostarska-Srokosz E, et al. Ultrasonografia płuc u pacjenta z rozsianym czerniakiem leczonym niwolumabem. Oncology in Clinical Practice. 2021; 17(2): 85–88.
  9. Młot B, Rzepecki P. Zaburzenia rytmu i przewodzenia serca w onkologii. Onkologia po Dyplomie. 2021.
  10. Cates CU, Virmani R, Vaughn WK, et al. Electrocardiographic markers of cardiac metastasis. Am Heart J. 1986; 112(6): 1297–1303.
  11. Brugada P, Brugada J, Mont L, et al. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation. 1991; 83(5): 1649–1659.
  12. Jastrzebski M, Sasaki K, Kukla P, et al. The ventricular tachycardia score: a novel approach to electrocardiographic diagnosis of ventricular tachycardia. Europace. 2016; 18(4): 578–584.